NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Oregon U-turns on Doubling Psilocybin License Fees
After weeks of organized resistance in the form of public comments, Oregon's health regulators have shelved a proposal that would have doubled what psilocybin businesses and facilitators pay for their state licenses. ...
Horizons 2026: New Medicines for an Old System
As pharmaceutical companies and mainstream medicine increasingly embrace psychedelic therapies, attendees at the nineteenth Horizons conference examined barriers to access and the broader paradox of how psychedelics c...
New Mexico Medical Psilocybin Program Regulation Changes Spark Outcry
Clinicians, advocates and lawmakers rebuked the New Mexico Health Department over restrictive draft psilocybin-assisted therapy rules. The post New Mexico Medical Psilocybin Program Regulation Changes Spark Outcry fir...
Psilocybin in the UK: Research, Regulation and Access Landscape in 2026
This article was originally published on Mind Forward.
FDA Holds Historic Public Hearing on Psychedelic Therapies
A highly anticipated public hearing at the FDA focused on questions about credentialing providers of psychedelic-assisted therapies, patient safety, data standardization, and equitable access to emerging therapies. Th...
Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New Drug Application (NDA) for MDMA-assisted therapy for PTSD to the FDA, triggering a fresh review cycl...
Weekly Psychedelic Policy Briefing β August 14, 2026
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research organization ICON will bring Anthropic's Claude AI tool into clinical trials involving drug developme...
Psychedelic Policy Briefing
In this week's psychedelic policy briefing, investigative journalist Jack Gorsline unpacks a wave of state and federal initiatives aimed at expanding alternative therapies for veterans and those battling addiction. Th...
Approval Is Not Access: A Postcard From Psychedelic Europe
At ICPR 2026 at the historic city ofin Haarlem in the Netherlands, the companies racing to turn psychedelics into approved medicines were nowhere to be found, leaving a hall full of researchers, clinicians, and one re...
Truffles, therapy, disciplinary law β An OPEN perspective on the grey area in which (licensed) therapists operate in the Netherlands with regard to psychedelics
Read this article in Dutch here. On May 8, 2026, the Amsterdam Healthcare Disciplinary Board ruled on a significant case in which the Health and Youth Care Inspectorate (IGJ) had filed a complaint against a clinical p...
Truffels, therapie, tuchtrecht: Een OPEN perspectief op het grijze gebied waarin (BIG-geregistreerde) therapeuten opereren in Nederland met betrekking tot psychedelica
Op 8 mei 2026 deed het Regionaal Tuchtcollege voor de Gezondheidszorg Amsterdam uitspraak in een belangwekkende zaak, waarin de Inspectie Gezondheidszorg en Jeugd (IGJ) een klacht had ingediend tegen een klinisch psyc...
Football Player Jordan Poyer Leads the Breath of Life Tour
Football player Jordan Poyer found healing with ayahuasca and is bringing his awareness of psychedelic medicines and breathwork to his Breath of Life tour. The post Football Player Jordan Poyer Leads the Breath of Li...
Activists March for Cognitive Liberty in NYC and Advocate in San Francisco
Psychedelic advocates organized by the Psychedelic Assembly marched through the streets of Manhattan to support cognitive liberty which was also championed on stage at the Psychedelic Culture conference in San Francis...
Trump Signs Executive Order To Fast-Track Psychedelic Research
President Donald Trump signed an executive order aimed at accelerating clinical research and federal approval for psychedelic therapies especially ibogaine as mental health therapy for veterans. The post Trump Signs E...
Trump Issues Executive Order to Accelerate Psychedelics for Mental Health
President Donald J. The post Trump Issues Executive Order to Accelerate Psychedelics for Mental Health appeared first on Psychedelic Health.